Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer

Genitourinary Cancer

Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history

BJU Int

Cannoletta D, Stabile A, Quarta L, Barletta F, Pellegrino F, Scuderi S, Porzi ME, Scilipoti P, Robesti D, Longoni M, Mazzone E, Brembilla G, De Cobelli F, Gandaglia G, Karnes JR, Roupret M, Montorsi F, Briganti A

doi: 10.1111/bju.70027

Genitourinary Cancer

Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided Biopsy and Focal Therapy

J Urol

Martin SC, Gonzalez S, Kwan L, Delfin M, Nguyen AV, Brisbane W, Felker E, Sisk A, Priester A, Natarajan S, Marks LS

doi: 10.1097/JU.0000000000004559

Genitourinary Cancer

Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial

Eur Urol

Al-Monajjed R, Boschheidgen M, Lakes J, Krilaviciute A, Radtke JP, Schlemmer HP, Bonekamp D, Herkommer K, Jahnen M, Gschwend JE, Düx D, Wacker F, Makowski MR, Sauter A, Kuczyk MA, Harke N, Debus J, Grott C, Arsov C, Seibold P, Hadaschik B, Giesel F, Kristiansen G, Antoch G, Becker N, Kaaks R, Schimmöller L, Albers P

doi: 10.1016/j.eururo.2025.05.020

Genitourinary Cancer

Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound Versus MRI/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study

J Urol

Borges RC, Tourinho-Barbosa RR, Dias N, de Barros Pena Ribeiro Paiva G, Glina S, Claros OR, Sanchéz LR, Rozet F, Barret E, Barbé YP, Lanz C, Sanchez-Salas R, Cathelineau X, Macek P, Korkes F

doi: 10.1097/JU.0000000000004793

Genitourinary Cancer

Does a Negative Prostate Biopsy Reduce the Risk of Prostate Cancer Reclassification in an Active Surveillance Protocol? An Updated Systematic Review and Meta-Analysis

Prostate

Bahri RA, Mohammadi A, Yar EZ, Rezayat M, Heshmat R, Aghamir SMK

doi: 10.1002/pros.24851

Genitourinary Cancer

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment

BJU Int

de Vos II, Marenghi C, Badenchini F, Boevé ER, Lozano-Uruñuela F, Graefen M, Rannikko AS, Staerman F, Sugimoto M, Kato T, Somford DM, Frydenberg M, Bangma CH, Remmers S, Roobol MJ, Prostate Cancer Research International: Active Surveillance (PRIAS) consortium

doi: 10.1111/bju.16727

Genitourinary Cancer

Diagnostic Utility of 18F-DCFPyL PSMA PET/CT-Ultrasound Fusion Biopsies Across the Prostate Cancer Spectrum

Prostate

Tillu N, Schussel K, P Kolanukuduru K, Choudhary M, Kacagan C, Falagario U, Agarwal Y, Mandel A, Maheshwari A, Sur H, Jodka H, David RB, Eraky A, Wagaskar V, Luz MA, Tewari A

doi: 10.1002/pros.70068

Genitourinary Cancer

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review

Prostate

Mondia MWL, Batchala PP, Dreicer R, Devitt ME, McCord MR, Mut M, Sheehan JP, Schiff D, Fadul CE

doi: 10.1002/pros.24890

Genitourinary Cancer

Efficacy and Safety of Enzalutamide and Abiraterone Plus Prednisolone in Elder Castration-Resistant Prostate Cancer Patients: A Sub-Analysis From the ENABLE Study

Prostate

Okamura T, Izumi K, Kurokawa S, Shima T, Kato Y, Mita K, Kamiyama M, Inoue S, Hoshi S, Tanaka N, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A

doi: 10.1002/pros.24897

Related content

Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history

Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided Biopsy and Focal Therapy

Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial

Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound Versus MRI/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study

Does a Negative Prostate Biopsy Reduce the Risk of Prostate Cancer Reclassification in an Active Surveillance Protocol? An Updated Systematic Review and Meta-Analysis

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment

Diagnostic Utility of 18F-DCFPyL PSMA PET/CT-Ultrasound Fusion Biopsies Across the Prostate Cancer Spectrum

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review

Efficacy and Safety of Enzalutamide and Abiraterone Plus Prednisolone in Elder Castration-Resistant Prostate Cancer Patients: A Sub-Analysis From the ENABLE Study